These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9111707)

  • 1. Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapy.
    Culig Z; Hobisch A; Hittmair A; Cronauer MV; Radmayr C; Bartsch G; Klocker H
    Drugs Aging; 1997 Jan; 10(1):50-8. PubMed ID: 9111707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy.
    Culig Z; Klocker H; Bartsch G; Hobisch A
    Am J Pharmacogenomics; 2001; 1(4):241-9. PubMed ID: 12083956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens, antiandrogens and androgen receptor abnormalities.
    Kuil CW; Brinkmann AO
    Eur Urol; 1996; 29 Suppl 2():78-82. PubMed ID: 8717468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen signal transduction and prostatic carcinoma.
    Klocker H; Culig Z; Kaspar F; Hobisch A; Eberle J; Reissigl A; Bartsch G
    World J Urol; 1994; 12(2):99-103. PubMed ID: 8087144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?
    Culig Z; Hobisch A; Hittmair A; Peterziel H; Radmayr C; Bartsch G; Cato AC; Klocker H
    Histol Histopathol; 1997 Jul; 12(3):781-6. PubMed ID: 9225161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Hara T; Miyazaki J; Araki H; Yamaoka M; Kanzaki N; Kusaka M; Miyamoto M
    Cancer Res; 2003 Jan; 63(1):149-53. PubMed ID: 12517791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
    Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
    BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
    Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
    Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
    Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
    Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
    Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS
    Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.
    Suzuki H; Akakura K; Komiya A; Aida S; Akimoto S; Shimazaki J
    Prostate; 1996 Sep; 29(3):153-8. PubMed ID: 8827083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
    Fenton MA; Shuster TD; Fertig AM; Taplin ME; Kolvenbag G; Bubley GJ; Balk SP
    Clin Cancer Res; 1997 Aug; 3(8):1383-8. PubMed ID: 9815822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiandrogen withdrawal syndrome.
    Wirth MP; Froschermaier SE
    Urol Res; 1997; 25 Suppl 2():S67-71. PubMed ID: 9144890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft.
    Terada N; Shimizu Y; Yoshida T; Maeno A; Kamba T; Inoue T; Nakamura E; Kamoto T; Ogawa O
    Prostate; 2010 Feb; 70(3):252-61. PubMed ID: 19790238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient.
    Yoshida T; Kinoshita H; Segawa T; Nakamura E; Inoue T; Shimizu Y; Kamoto T; Ogawa O
    Cancer Res; 2005 Nov; 65(21):9611-6. PubMed ID: 16266977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3 beta-acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity.
    Miyamoto H; Marwah P; Marwah A; Lardy H; Chang C
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4440-4. PubMed ID: 12672951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiandrogen withdrawal syndrome associated with prostate cancer therapies: incidence and clinical significance.
    Paul R; Breul J
    Drug Saf; 2000 Nov; 23(5):381-90. PubMed ID: 11085345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The androgen receptor gene and its influence on the development and progression of prostate cancer.
    Montgomery JS; Price DK; Figg WD
    J Pathol; 2001 Sep; 195(2):138-46. PubMed ID: 11592091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.